While this effect was not statistically significant, it supports the idea that NK cells may play a limited role in tumour control in IL17A‐proficient contexts, in line with our previous findings that CD4+ T cells are the predominant effectors in these settings.15 The gene discussed is IL17A; the disease is neoplasm.